Doctors Have New Insights into Flakka and Kratom Because of New Testing Capabilities by Ameritox Investments


Today Ameritox, a national leader in medication monitoring solutions, announced it is offering tests for two dangerous street drugs, flakka and kratom. The additions are in response to reports from clinicians and state and federal law enforcement about the potential for abuse of these two substances among those who misuse or abuse prescription drugs.

“We determine the need for a new test by regularly speaking with the physicians we serve – finding out what they’re hearing and seeing in their communities,” said Ameritox Chief Medical Officer, Dr. Tom Smith. “We also monitor DEA notices and law enforcement alerts about dangerous new drugs. We added flakka and kratom to our testing options because they’re a growing concern for the patients our clinicians care for.”

“Candidly, flakka and kratom are still relatively new street drugs, the effects of which aren’t completely understood,” Smith said. “The benefit of knowing whether patients are using these drugs will help protect them from potential tragedy.”

PR Newswire

Kratom Supplements t
3 Things Pharmacists
Rate This Article: